申请人:Merck Frosst Canada, Inc.
公开号:US06020343A1
公开(公告)日:2000-02-01
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
这项发明涵盖了用于治疗环氧合酶-2介导疾病的新型化合物I的公式。该发明还涵盖了用于治疗环氧合酶-2介导疾病的某些药物组合物,包括化合物I的公式。